Journals / Meme Sağlığı Dergisi / 2010 / Cilt: 6 - Sayı: 4

Menopozda hormon replasman tedavisi; mammografik bulgulardaki değişiklikler

Pages
168–169
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ALTINBAŞ, N. K., ALTINBAŞ, S. K., ALTINMABAŞ, M. (2010). Menopozda hormon replasman tedavisi; mammografik bulgulardaki değişiklikler. Meme Sağlığı Dergisi, Cilt: 6 - Sayı: 4, 168–169. https://ajindex.com/articles/278239

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Box BA, Russell CA. Breast cancer. In: Casciato DA, ed. Manual of Clinical Oncology. 5th ed. Philadelphia, Lippincott Williams & Wilkins 2004:233-253
  2. Valdivia I, Ortega D. Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Invest 2000; 20:101-107
  3. Lundström E, Christow A, Kersemaekers W, Swane G, Azavedo E, Söderqvist G, Mol-Arts M, Barkfeldt J, Scholutz B. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002; 186:717- 722. (PMID: 11967497
  4. Pegram MD, Casciato DA. Breast cancer. In: Casciato DA, Territo MC eds. Manual of Clinical Oncology. 5th ed. Philadelphia, W Kluwer / Lippincott Williams & Wilkins 2009: 237-264
  5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative (WHI) randomized controlled trial. JAMA 2002; 288:321-333. (PMID: 12117397
  6. Beckmann MW, Kiesel L, Braendle W,et al. Konsensusempfehlungen zur Hormontherapie im Klimakterium und in der Potmenopause. Senologie 2004; 1:33-36
  7. Holmberg L, Anderson H. HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer, is it safe ?), a randomized comparison: trial stopped. Lancet 2004; 363:453-455. (PMID: 14962527) 8) von Schoultz E, Rutqvist LE; Stockholm Breast Cancer Study Group. Menopausal hormone therapy after breast cancer: The Stockholm randomized trial. J Natl Cancer Inst 2005; 97:533-535. (PMID: 15812079
  8. Marsden J. The menopause, hormone replacement therapy and breast cancer. J Steroid Biochem Mol Biol 2002; 83:123-132. (PMID: 12650709
  9. Coombs NJ, Taylar R, Wilcken N, Fiorica J, Boyages J. Hormone replacement therapy and breast cancer risk in California. Breast J 2005; 11;410-415. (PMID: 16297085)